The observed power of the repeated-measures analysis of the biomarker levels late after LDLT with HCC recurrence showed that the power of FGF-2 (1.000) was > survivin (0.999) > Ki67 (0.949) > endostatin (0.411) > VEGF (0.305) (Table 2). This evidence concerns the gene BIRC5 and hepatocellular carcinoma.